These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36301749)

  • 1. Patients with hereditary angioedema and their treatment patterns in Germany: a Delphi consensus study.
    Martinez-Saguer I; Dominas N; Straben U; Greve J; Brehler R; Magerl M; Knipps LM; Knop J; Flemming A; Schubert T; Maurer M
    Eur J Dermatol; 2022 Jul; 32(4):487-494. PubMed ID: 36301749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries.
    Wahn V; Aberer W; Aygören-Pürsün E; Bork K; Eberl W; Faßhauer M; Krüger R; Magerl M; Martinez-Saguer I; Späth P; Staubach-Renz P; Weber-Chrysochoou C
    Pediatr Allergy Immunol; 2020 Nov; 31(8):974-989. PubMed ID: 32524650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis in hereditary angioedema: a United Kingdom Delphi consensus.
    Yong PFK; Annals R; Diwakar L; Elkhalifa S; Gompels M; Jain R; Karim MY; Khan S; Metcalfe A; Noorani S; Steele C; Kiani-Alikhan S; Garcez T
    Clin Exp Immunol; 2024 Jun; 217(1):109-116. PubMed ID: 38456386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A; Caccia S; Cicardi M
    Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
    Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
    Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
    Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L
    J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
    Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J; Neeno T
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Long-Term Prophylactic Treatment With Subcutaneous C1 Esterase Inhibitor in a Patient With Hereditary Angioedema.
    Hahn J; Nordmann-Kleiner M; Trainotti S; Hoffmann TK; Greve J
    J Pharm Pract; 2020 Dec; 33(6):907-911. PubMed ID: 31234699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency.
    Craig T; Busse P; Gower RG; Johnston DT; Kashkin JM; Li HH; Lumry WR; Riedl MA; Soteres D
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):673-679. PubMed ID: 30056152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
    Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
    Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema.
    Kaplan AP; Pawaskar D; Chiao J
    J Allergy Clin Immunol Pract; 2020 Mar; 8(3):892-900. PubMed ID: 31655295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
    Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
    J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert Review and Consensus on the Treat-to-Target Management of Hereditary Angioedema: From Scientific Evidence to Clinical Practice.
    Caballero T; Lleonart-Bellfill R; Pedrosa M; Ferrer L; Guilarte M
    J Investig Allergol Clin Immunol; 2023 Jul; 33(4):238-249. PubMed ID: 36811842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience.
    Cancian M;
    Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):383-91. PubMed ID: 26106828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States.
    Riedl MA; Banerji A; Manning ME; Burrell E; Joshi N; Patel D; Machnig T; Tai MH; Watson DJ
    Orphanet J Rare Dis; 2018 Oct; 13(1):180. PubMed ID: 30314518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
    Riedl M
    Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.